A DENTAL nurse claims she blew enough cash to buy “ten Mercedes” on her ketamine addiction – which left her using the ...
Urology departments in England and Wales have reported seeing an increase in the number of 16- to 24-year-olds being admitted ...
DelveInsight's Underactive Bladder Syndrome Market Insights report includes a comprehensive understanding of current ...
Urology departments in England and Wales have seen an increase in bladder inflammation among 16 to 24-year-olds ...
Ketamine abuse is rising among young adults, causing severe bladder damage, pain, and lasting health risks.
Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer ...
The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva, a groundbreaking cancer therapy, for ...
The underactive bladder syndrome market is expected to grow steadily, driven by an aging global population and rising prevalence of neurogenic and chronic conditions affecting bladder function.
I'm trained to treat conditions I used to see mainly in older patients - but now it's all teenagers and people in their early ...
West Tennessee Healthcare is pleased to announce a new treatment option for people living with urge urinary incontinence (UUI ...
Saudi Gazette on MSN
SFDA approves registration of 'Anktiva' for treatment of bladder and lung cancer
Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in combination with immunotherapy for adult patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results